UK Parliament approves Brexit bill, govt to begin exit process by Mar 31

March 14, 2017

Washington, Mar 14: Britain lurched closer to leaving the European Union Monday when Parliament stopped resisting and gave Prime Minister Theresa May the power to file for divorce from the bloc.

brexit

But in a blow to May's government, the prospect of Scotland's exit from the United Kingdom suddenly appeared nearer, too. Scottish First Minister Nicola Sturgeon called for a referendum on independence within two years to stop Scotland being dragged out of the EU against its will.

Amid Britain's divorce from EU, Scotland wants Independence

In an announcement that took many London politicians by surprise, Sturgeon vowed that Scotland would not be "taken down a path that we do not want to go down without a choice." Sturgeon spoke in Edinburgh hours before the European Union (Notification of Withdrawal) Bill passed its final hurdle in Parliament's upper chamber, the House of Lords.

The House of Commons approved the bill weeks ago, but the 800-strong Lords fought to amend it, inserting a promise that EU citizens living in the U.K. will be allowed to remain after Britain pulls out of the bloc.

They also added a demand that Parliament get a "meaningful" vote on the final deal between Britain and the remaining 27 EU nations.

Both amendments were rejected Monday by the Commons, where May's Conservatives have a majority. A handful of pro-EU Conservatives expressed their unhappiness, then abstained from the vote. The bill returned to the Lords, in a process known as parliamentary ping pong. Faced with the decision of the elected Commons, the Lords backed down and approved it without amendments.

Labour peer Dianne Hayter, who proposed the amendment on EU citizens, said the Lords had done their best, but "our view has been rejected in the elected House of Commons, and it is clear the government is not for turning."

Once the bill receives royal assent - a formality that should be accomplished within hours - May will be free to invoke Article 50 of the EU's key treaty, triggering two years of exit negotiations, by her self-imposed deadline of March 31.

May was forced to seek Parliament's approval for the move after a Supreme Court ruling in January torpedoed her attempt to start the process of leaving the bloc without a parliamentary vote.

Debate between House of Commons and House of Lords

The House of Commons and House of Lords battled over the bill's contents, with the status of EU nationals in Britain - and Britons in fellow EU member countries - drawing especially emotional debate. Both British and EU officials have said such residents should be guaranteed the right to stay where they are, but the two sides have so far failed to provide a concrete guarantee, leaving millions of people in limbo.

Scottish National Party lawmaker Joanna Cherry told the House of Commons that one constituent, a Lithuanian, had told her "the uncertainty caused by this government and this Parliament is making her feel worse about her personal situation in Britain than she did in Lithuania under the Soviets."

Brexit Secretary David Davis told lawmakers the government had a "moral responsibility" to the 3 million EU citizens living in Britain and the 1 million Britons in other member states, and intends to guarantee their rights as soon as possible after exit talks start.

"That is why we must pass this straightforward bill without further delay, so the prime minister can get to work on the negotiations and we can secure a quick deal that secures the status of both European Union citizens in the U.K. and also U.K. nationals living in the EU," he said.

Pro-EU lawmakers accused the government and Brexit-backing lawmakers of running roughshod over the concerns of the 48 percent of Britons who voted to stay in the EU.

Conservative legislator Dominic Grieve called the government's opposition of handing Parliament a final vote on Brexit "deranged," and the Green Party's Caroline Lucas said lawmakers should not just hand ministers a blank check.

"We were not elected to be lemmings," Lucas said.

Euroskeptics accused pro-EU legislators of trying to frustrate the will of voters who passed a June referendum to leave the EU.

"The simple truth is this - deal or no deal, vote or no vote, positive vote or negative vote, this process is irreversible," Conservative legislator Edward Leigh said. "We're leaving the EU, and that's what the people want."

May is now free to trigger Article 50 as early as Tuesday, but the government signaled the move would come much closer to the March 31 deadline. May spokesman James Slack repeated the government's position that it would happen by the end of March.

"I've said 'end' many times, but it would seem I didn't put it in capital letters strongly enough," he said.Political union under threat

The government's satisfaction at victory in Parliament was tempered by the prospect of an independence vote that threatens the 300-year old political union between England and Scotland.

Sturgeon said she would seek to hold a referendum between the fall of 2018 and the spring of 2019 so Scottish voters could make an "informed choice" about their future. While Britons overall voted to leave the EU, Scottish voters backed remaining by 62 to 38 percent, and Sturgeon said they should not be forced to follow the rest of the U.K. into a "hard Brexit" outside the EU single market.

In a 2014 referendum, Scottish voters rejected independence by a margin of 55 percent to 45 percent. But Sturgeon said the U.K.'s decision to leave the EU had brought about a "material change of circumstances."

May - whose government would have to approve a legally binding referendum - accused Sturgeon's Scottish National Party of political "tunnel vision" and called her announcement "deeply regrettable."

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 25,2020

Hubei, Mar 25: As a bus departed from its terminus at Hankou Railway Station at 5:25 am Wednesday morning, Wuhan started to resume bus service after nine weeks of lockdown.

Apart from a driver, a safety supervisor was also on each bus, whose duty was to make sure all passengers are healthy.
"For those who do not use smartphones, they should bring with them a health certificate issued by the health authorities," said Zhou Jingjing, a safety supervisor aboard bus No. 511 departing from the Wuchang Railway Station complex.
The once hardest-hit city in central China's Hubei Province during the COVID-19 outbreak took unprecedented traffic restrictions on Jan 23. All of its public transport and all outbound flights and trains had been suspended in an attempt to contain the virus within the region.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
January 20,2020

Wuhan, Jan 20: A 45-year-old Indian woman has become the first foreigner in China to have contracted a mysterious virus, which is suspected to be Severe Acute Respiratory Syndrome (SARS)-like corona virus.

In 2002-2003, the SARS corona virus killed around 650 people in China and Hong Kong. This time, a new strain of virus with 62 cases have been reported in Wuhan and two in Shenzhen so far. 19 patients have been already cured and discharged, as per the Chinese media.

Official sources in Beijing said that the patient, Preeti Maheshwari, a school teacher at an international school, is undergoing treatment for the new strain of pneumonia outbreak, which has been spreading in two major cities of China - Wuhan and Shenzen. She has been on a ventilator in the intensive care unit.

Maheshwari was admitted to a local hospital after she seriously fell ill last Friday. Her husband, a businessman from Delhi, is allowed to visit her daily.

Following a second death due to the outbreak of the virus in Wuhan, India on Friday issued an advisory to its nationals travelling to China. Over 500 Indian medical students are studying in Wuhan.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 4,2020

Jun 4: A malaria drug President Donald Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality study to test it in people in close contact with someone with the disease.

Results published Wednesday by the New England Journal of Medicine show that hydroxychloroquine was no better than placebo pills at preventing illness from the coronavirus.

The drug did not seem to cause serious harm, though -- about 40% on it had side effects, mostly mild stomach problems.

 “We were disappointed. We would have liked for this to work,” said the study leader, Dr. David Boulware, an infectious disease specialist at the University of Minnesota.

“But our objective was to answer the question and to conduct a high-quality study,” because the evidence on the drug so far has been inconclusive, he said.

Hydroxychloroquine and a similar drug, chloroquine, have been the subject of much debate since Trump started promoting them in March.

Hydroxychloroquine has long been used for malaria, lupus, and rheumatoid arthritis, but no large studies have shown it or chloroquine to be safe or effective for much sicker patients with coronavirus, and some studies have suggested the drugs may do harm.

Trump took a two-week course of hydroxychloroquine, along with zinc and Vitamin D, after two staffers tested positive for COVID-19, and had no ill effects, according to results of his latest physical released by his doctor Wednesday.

Federal regulators have warned against hydroxychloroquine's use except in hospitals and formal studies because of the risk of side effects, especially heart rhythm problems.

Boulware's study involved 821 people in the United States and Canada living with someone diagnosed with COVID-19 or at high risk of getting it because of their job -- doctors, nurses, ambulance workers who had significant exposure to a sick patient while not wearing full protective gear.

They were randomly assigned to get either the nutrient folate as a placebo or hydroxychloroquine for five days, starting within four days of their exposure. Neither they nor others involved in the research knew who was getting which pills.

After 14 days in the study, 12 per cent on the drug developed COVID-19 symptoms versus 14 per cent in the placebo group, but the difference is so small it could have occurred by chance, Boulware said.

“There's basically no effect. It does not prevent infection,” he said of the drug. Even if it were to give some slim advantage, “we'd want a much larger effect” to justify its use and risk of side effects for preventing illness, he said.

Results were no different among a subgroup of participants who were taking zinc or vitamin C, which some people believe might help make hydroxychloroquine more effective or fight the coronavirus.

There are some big caveats: The study enrolled people through the Internet and social media, relying on them to report their own symptoms rather than having them tracked in a formal way by doctors.

Participants were not all tested for the coronavirus but were diagnosed as COVID-19 cases based on symptoms in many cases. And not all took their medicines as directed.

The results “are more provocative than definitive,” and the drug may yet have prevention benefits if tried sooner or in a different way, Dr. Myron Cohen of the University of North Carolina at Chapel Hill wrote in a commentary in the journal.

Others were glad to see a study that had a comparison group and good scientific methods after so many weaker reports on hydroxychloroquine.

“This fits with everything else we've seen so far which suggests that it's not beneficial," said Dr. Peter Bach, director of a health policy center at Memorial Sloan Kettering Cancer Center in New York.

This study was in younger relatively healthy people, but the results “would make me very discouraged about trying to use this in older people” who are most vulnerable to serious illness from the coronavirus, Bach said.

“If it does work, it doesn't work very well.” Dr. Dan Culver, a lung specialist at the Cleveland Clinic, said there's still a chance that giving the drug sooner than four days after someone's exposure to the virus may help prevent illness.

But the study “takes 'home run' off the table” as far as hopes for the drug, he said.

The study was mostly funded by David Baszucki, founder of Roblox, a California-based game software company, and other private donors and the Minnesota university.

Boulware also is leading a study testing hydroxychloroquine for treating COVID-19. The study is finished and results are being analyzed now.

On Tuesday, the journal Lancet posted an “expression of concern” about a study it published earlier this month of nearly 15,000 COVID-19 patients on the malaria drugs that tied their use to a higher risk of dying in the hospital or developing a heartbeat problem.

Scientists have raised serious questions about the database used for that study, and its authors have launched an independent audit.

That work had a big impact: the World Health Organization suspended use of hydroxychloroquine in a study it is leading, and French officials stopped the drug's use in hospitals. On Wednesday, the WHO said experts who reviewed safety information decided that its study could resume.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.